⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

PHIO News

Phio Pharmaceuticals Corp. Common Stock

Phio Pharmaceuticals Announces Positive Pathology Results: Final Maximum Dose Cohort for INTASYL PH-762 Skin Cancer Trial